Presentations at the Spring Symposium of ASA NJ-chapter
2005 -  
  Ana Szarfman         Use of Advanced Computer Methods to Simplify the Analysis of Complex Clinical Trial Safety Data.
  Richard D. De Veaux  Data Mining in the Real World: Five Lessons Learned in the Pit.
  William DuMouchel    Empirical Bayes Methods for Estimation of Adverse Event Rates.
  Lyle Ungar           Genomic Data Mining.

 2003 -  
   Stephen George   Advising the FDA: A Statistician's Perspective.
   Richard Pazdur   Defining Success in Oncology Drug Development.
   Lawrence Gould   Using Bayesian Calculations To Address Clinical Trial Issues Directly.
   Danyu Lin        Estimating the proportion of treatment effect explained by a surrogate marker

 2002 -  
   Gordon Lan       Problems and issues in adaptive clinical trial design.
   Cyrus R. Mehta   On the Inefficiency of the Adaptive Design for Monitoring Clinical Trials. 
		    Symposium on Group Sequential Inference.
   Chris Jennison   Flexible Sample Size: Is There a Free Lunch? 
   James Hung       Inference and Operational Conduct Issues with Sample Size Adjustment Based 
		    On Interim Observed Effect Size.
   Lloyd Fisher     Self-Designing Trials: Further Thoughts & Advances.

 2001 -  
   Richard Simon    Therapeutic Equivalence & Active Control Clinical Trials.
   Bob O'Neill      An Update on Statistical Issues Associated with the International 
	            Harmonization of Technical Standards for Clinical Trials (ICH).
   Steve Wilson     Developing e-Standards for Clinical Trials Data and Analyses.            
   Michael Walega   Industry Standards for the Electronic Submission of Data to the FDA.